Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.
Amodio N, Di Martino MT, Foresta U, Leone E, Lionetti M, Leotta M, Gullà AM, Pitari MR, Conforti F, Rossi M, Agosti V, Fulciniti M, Misso G, Morabito F, Ferrarini M, Neri A, Caraglia M, Munshi NC, Anderson KC, Tagliaferri P, Tassone P. Amodio N, et al. Among authors: anderson kc. Cell Death Dis. 2012 Nov 29;3(11):e436. doi: 10.1038/cddis.2012.175. Cell Death Dis. 2012. PMID: 23190608 Free PMC article.
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.
Morelli E, Leone E, Cantafio ME, Di Martino MT, Amodio N, Biamonte L, Gullà A, Foresta U, Pitari MR, Botta C, Rossi M, Neri A, Munshi NC, Anderson KC, Tagliaferri P, Tassone P. Morelli E, et al. Among authors: anderson kc. Leukemia. 2015 Nov;29(11):2173-83. doi: 10.1038/leu.2015.124. Epub 2015 May 19. Leukemia. 2015. PMID: 25987254 Free PMC article.
miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth.
Fulciniti M, Amodio N, Bandi RL, Cagnetta A, Samur MK, Acharya C, Prabhala R, D'Aquila P, Bellizzi D, Passarino G, Adamia S, Neri A, Hunter ZR, Treon SP, Anderson KC, Tassone P, Munshi NC. Fulciniti M, et al. Among authors: anderson kc. Blood Cancer J. 2016 Jan 15;6(1):e380. doi: 10.1038/bcj.2015.106. Blood Cancer J. 2016. PMID: 26771806 Free PMC article.
CSNK1α1 mediates malignant plasma cell survival.
Hu Y, Song W, Cirstea D, Lu D, Munshi NC, Anderson KC. Hu Y, et al. Among authors: anderson kc. Leukemia. 2015 Feb;29(2):474-82. doi: 10.1038/leu.2014.202. Epub 2014 Jun 25. Leukemia. 2015. PMID: 24962017 Free PMC article.
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.
Neri P, Tassone P, Shammas M, Yasui H, Schipani E, Batchu RB, Blotta S, Prabhala R, Catley L, Hamasaki M, Hideshima T, Chauhan D, Jacob GS, Picker D, Venuta S, Anderson KC, Munshi NC. Neri P, et al. Among authors: anderson kc. Leukemia. 2007 Dec;21(12):2519-26. doi: 10.1038/sj.leu.2404912. Epub 2007 Sep 20. Leukemia. 2007. PMID: 17882285
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.
Calimeri T, Battista E, Conforti F, Neri P, Di Martino MT, Rossi M, Foresta U, Piro E, Ferrara F, Amorosi A, Bahlis N, Anderson KC, Munshi N, Tagliaferri P, Causa F, Tassone P. Calimeri T, et al. Among authors: anderson kc. Leukemia. 2011 Apr;25(4):707-11. doi: 10.1038/leu.2010.300. Epub 2011 Jan 14. Leukemia. 2011. PMID: 21233838 Free PMC article. No abstract available.
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.
Shammas MA, Koley H, Bertheau RC, Neri P, Fulciniti M, Tassone P, Blotta S, Protopopov A, Mitsiades C, Batchu RB, Anderson KC, Chin A, Gryaznov S, Munshi NC. Shammas MA, et al. Among authors: anderson kc. Leukemia. 2008 Jul;22(7):1410-8. doi: 10.1038/leu.2008.81. Epub 2008 May 1. Leukemia. 2008. PMID: 18449204 Free PMC article.
1,230 results